Survivin-derived peptides and use thereof

Details for Australian Patent Application No. 2004208469 (hide)

Owner Survac A/S

Inventors Straten, Eivind Per Thor; Andersen, Mads Hald

Agent FB Rice

Pub. Number AU-B-2004208469

PCT Pub. Number WO2004/067023

Priority 10/715,417 19.11.03 US; 10/354,090 30.01.03 US

Filing date 30 January 2004

Wipo publication date 12 August 2004

Acceptance publication date 13 May 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/067023 Priority application(s): WO2004/067023

13 May 2010 Application Accepted

  Published as AU-B-2004208469

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004208476-Pseudo-isothermal radial reactor

2004208460-Limposomes containing asiaticoside and the uses thereof